![](/img/cover-not-exists.png)
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigenPlasmodium falciparumFVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, Margaret Koech…Volume:
12
Language:
english
DOI:
10.1186/1475-2875-12-29
Date:
December, 2013
File:
PDF, 328 KB
english, 2013